Andreas Kjær Selected Research

Andreas Kjær Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 11/2010
8	Inflammation (Inflammations) 10/2020 - 07/2011
7	Myocardial Infarction 01/2020 - 05/2014
6	Type 2 Diabetes Mellitus (MODY) 03/2022 - 03/2014
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2011
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2018 - 01/2011
6	Hypoxia (Hypoxemia) 01/2018 - 06/2012
6	Carcinoma (Carcinomatosis) 01/2018 - 06/2012
5	Heart Failure 01/2021 - 12/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2018
5	Fibrosis (Cirrhosis) 01/2018 - 01/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 07/2011
5	Ovarian Neoplasms (Ovarian Cancer) 04/2013 - 09/2010
4	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022 - 01/2016
4	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2016
4	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 06/2012
4	Neoplasm Metastasis (Metastasis) 11/2019 - 12/2014
4	Atherosclerosis 12/2016 - 08/2011
4	Atherosclerotic Plaque (Atheroma) 02/2016 - 07/2015
3	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2018
3	Carcinoid Tumor (Carcinoid) 01/2021 - 12/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 05/2011
3	Infarction (Infarctions) 01/2019 - 10/2015
3	Neuroendocrine Carcinoma 01/2016 - 06/2012
2	Hypertrophy 03/2022 - 03/2012
2	Meningioma (Meningiomas) 10/2020 - 01/2020
2	Lymphoma (Lymphomas) 10/2020 - 01/2020
2	Cardiotoxicity 10/2020 - 01/2020
2	Adenocarcinoma 01/2020 - 10/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2017
2	Chronic Hepatitis C 01/2019 - 01/2014
2	Carcinogenesis 10/2018 - 12/2014
2	Insulin Resistance 01/2018 - 03/2014
2	Heart Diseases (Heart Disease) 01/2018 - 08/2011
2	Vascular Calcification 01/2018 - 01/2018
2	HIV Infections (HIV Infection) 12/2016 - 02/2016
2	Coronary Disease (Coronary Heart Disease) 02/2016 - 01/2016
2	Overweight 03/2014 - 11/2013
2	Colonic Neoplasms (Colon Cancer) 02/2014 - 01/2012
1	Diabetes Mellitus 03/2022
1	Unilateral Breast Neoplasms 10/2021
1	Lymphatic Metastasis 01/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2013
10	Liposomes (Liposome)IBA 01/2020 - 06/2012
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 03/2012
6	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2013
5	Biological ProductsIBA 01/2021 - 05/2016
5	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2020 - 06/2012
5	alovudineIBA 01/2020 - 09/2010
4	empagliflozinIBA 03/2022 - 11/2019
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 03/2014
4	Rubidium-82IBA 10/2020 - 01/2016
4	Radioisotopes (Radionuclides)IBA 10/2020 - 01/2011
4	pro-brain natriuretic peptide (1-76)IBA 03/2012 - 12/2010
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2022 - 05/2014
3	Liraglutide FDA Link 01/2021 - 03/2014
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2020 - 11/2010
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2017
3	LigandsIBA 10/2018 - 06/2012
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2014
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 01/2015
3	CalciumIBA 02/2016 - 08/2011
3	Peptides (Polypeptides)IBA 06/2012 - 11/2010
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 02/2017
2	AntigensIBA 10/2021 - 06/2012
2	CytokinesIBA 10/2020 - 10/2018
2	Adenosine (Adenocard)FDA LinkGeneric 10/2020 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 01/2020
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2020 - 01/2020
2	Peptide Receptors (Peptide Receptor)IBA 10/2020 - 01/2011
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 01/2014
2	NestinIBA 01/2019 - 07/2014
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2018 - 06/2012
2	MicroRNAs (MicroRNA)IBA 07/2018 - 12/2014
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 05/2018 - 06/2016
2	Phosphates (Orthophosphate)IBA 01/2018 - 01/2018
2	Lipopolysaccharide ReceptorsIBA 01/2018 - 12/2016
2	Pyruvic Acid (Pyruvate)IBA 01/2018 - 01/2015
2	alfacalcidolIBA 01/2018 - 01/2018
2	fibrin fragment D (D-dimer)IBA 12/2016 - 02/2012
2	CholesterolIBA 01/2016 - 01/2014
2	64Cu-DOTATATEIBA 12/2015 - 07/2015
2	Atrial Natriuretic Factor (ANF)IBA 03/2014 - 01/2012
2	Dobutamine FDA LinkGeneric 03/2014 - 01/2014
2	Adrenergic Agents (Adrenergic Drugs)IBA 03/2014 - 01/2014
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Glucagon (Glukagon)FDA Link 01/2021

Therapy/Procedure

21	Therapeutics 10/2021 - 01/2011
10	Radiotherapy 03/2022 - 07/2014
6	Drug Therapy (Chemotherapy) 10/2020 - 01/2012
5	Aftercare (After-Treatment) 10/2021 - 01/2012
2	Neck Dissection (Radical Neck Dissection) 11/2019 - 02/2016
2	Nephrectomy 01/2018 - 01/2018
2	Intravenous Injections 10/2017 - 06/2012
2	Art Therapy 05/2017 - 02/2016
2	Carotid Endarterectomy 07/2015 - 01/2013